X
Technology, Healthcare Jan 25, 2022 03:19 PM (GMT+8) · EqualOcean
On the 25th, Guangzhou Yinming Biomedical Technology Co., Ltd. announced that its subsidiary Zhuhai Qi Microbial Technology Co., Ltd. developed the world's first in class ophthalmic traditional Chinese medicine qa108 granule for dry age-related macular degeneration (dry AMD), On January 19, 2022, it has obtained the notice of approval of drug clinical trial from the State Drug Administration, and phase II clinical trial will be carried out soon.